We are live on ! Find out more
INSP icon

Inspire Medical Systems

374 hedge funds and large institutions have $6.68B invested in Inspire Medical Systems in 2023 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 156 increasing their positions, 101 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 28

54% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 101

20% more capital inflows, than outflows

Capital inflows: $850M | Capital outflows: $707M

11% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $37.3M

10% more funds holding

Funds holding: 340 → 374 (+34)

1.3% more ownership

Funds ownership: 97.63% → 98.93% (+1.3%)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
374
Holders Change
+34
Holders Change %
+10%
% of All Funds
5.95%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.11%
New
65
Increased
156
Reduced
101
Closed
28
Calls
$41.3​M
Puts
$37.3​M
Net Calls
+$4.05​M
Net Calls Change
-⁠$57.1​M

INSP Hedge Fund Activity: Q1 2023 in Review

374 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2023, worth a combined $6.68B — down 5.9% from $7.1B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new INSP positions and 28 closed out — a net gain of 37 holders — while 156 added to existing stakes and 101 trimmed.

The largest buyer was Invesco, adding an estimated $89.2M. The largest seller was Macquarie Group, cutting an estimated $117M.

  • 374 institutional investors held Inspire Medical Systems (INSP) as of Q1 2023, up from 340 in Q4 2022.
  • Funds reported $6.68B of Inspire Medical Systems stock for Q1 2023, down 5.9% quarter-over-quarter.
  • 65 funds opened new Inspire Medical Systems positions in Q1 2023 and 28 closed out, a net change of +37 holders.
  • The largest Inspire Medical Systems buyer in Q1 2023 was Invesco, an estimated $89.2M added.
  • The largest Inspire Medical Systems seller in Q1 2023 was Macquarie Group, an estimated $117M sold.

Based on aggregated 13F filings for Q1 2023.